This newsletter presents you the following key sessions:
1. PODCAST: Luis Paz-Ares about the CASPIAN study
2. Long-term results of MINDACT confirm MammaPrint as a guidance for adjuvant chemotherapy in breast
cancer patients
3. The clinical impact of COVID-19 on cancer patients
4. Chemotherapy-free regimen with niraparib and bevacizumab significantly improves clinical outcomes
in patients with recurrent platinum-sensitive ovarian cancer
5. Frontline pembrolizumab significantly delays the disease progression of patients with metastatic
colorectal cancer and a high microsatellite instability
Please consult the prescribing information before prescribing via https://www.famhp.be/en
